Theranica Reports Positive Study Results of Nerivio® for Adolescent Migraine Patients
USA - English
News provided by
Share this article
Share this article
NETANYA, Israel, Dec. 22, 2020 /PRNewswire/ Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that a new peer-reviewed study demonstrates the potential of remote electrical neuromodulation (REN) for the acute treatment of migraine in adolescents. The study used Theranica s Nerivio® therapeutic wearable, currently FDA-cleared for adult patients, and demonstrates that adolescents may also benefit from using the device. Nerivio is currently under review by the FDA for indication expansion to adolescents.
Dramatic Impact of Mindfulness on Migraine
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Survey Shows CBD Has Positive Impact on Migraines
hjnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hjnews.com Daily Mail and Mail on Sunday newspapers.
Medically Reviewed
iStock (2)
An estimated 39 million Americans have migraine, with symptoms that can range from mild to severe, according to the Migraine Research Foundation. Migraine attacks previously were thought to be a result of abnormal dilation of blood vessels in the brain, but scientists now believe that the cause may be more complex and involve inherited differences in brain chemistry.
Women are much more likely than men to have migraine, as are people with a family history of migraine, according to the Migraine Research Foundation.
But not all migraine attacks are alike, and not everyone has the same migraine symptoms, says neurologist Alexander Mauskop, MD, a founder and director of the New York Headache Center in Manhattan and White Plains, New York.